180 Life Sciences Corp. (ATNF)
NASDAQ: ATNF · Real-Time Price · USD
2.340
-0.010 (-0.43%)
Nov 20, 2024, 4:00 PM EST - Market closed
180 Life Sciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 2 | 2 | 7 | 133 | 76 | 912 | |
| Market Cap Growth | -53.21% | -68.80% | -94.83% | 74.01% | -91.64% | 8.20% | |
| Enterprise Value | 3 | -0 | 4 | 121 | 78 | 912 | |
| Last Close Price | 2.34 | 4.06 | 64.41 | 1482.00 | 1037.40 | 4063.64 | |
| PB Ratio | 0.64 | -16.75 | 0.60 | 3.37 | 2.52 | 23.65 | |
| P/TBV Ratio | - | - | 0.71 | 343.78 | - | 35099.59 | |
| Debt / Equity Ratio | 0.13 | -8.25 | 0.12 | 0.05 | 0.12 | 0.09 | |
| Quick Ratio | 0.03 | 0.48 | 1.34 | 0.45 | 0.14 | 0.04 | |
| Current Ratio | 0.19 | 0.72 | 1.58 | 0.57 | 0.19 | 0.08 | |
| Return on Equity (ROE) | -174.19% | -355.47% | -152.87% | -58.40% | -31.61% | -164.39% | |
| Return on Assets (ROA) | -51.62% | -67.63% | -27.16% | -16.53% | -6.57% | -48.89% | |
| Return on Capital (ROIC) | -180.04% | -123.78% | -41.46% | -25.95% | -9.27% | -75.76% | |
| Earnings Yield | -129.91% | -931.54% | -564.68% | -15.32% | -14.28% | -2.78% | |
| FCF Yield | -111.94% | -510.38% | -176.84% | -14.60% | -5.08% | -0.36% | |
| Buyback Yield / Dilution | -248.56% | -279.01% | -21.22% | -72.72% | -64.51% | - | |
| Total Shareholder Return | -248.56% | -279.01% | -21.22% | -72.72% | -64.51% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.